Disease Index
A
C
- California Serogroup Virus Diseases
- Campylobacteriosis
- Cancer
- Candida auris, clinical
- Carbon Monoxide Poisoning
- Chancroid
- Chikungunya
- Chlamydia
- Cholera
- Coccidioidomycosis
- COVID-19
- CP-CRE, Enterobacter spp.
- CP-CRE, Escherichia coli (E. coli)
- CP-CRE, Klebsiella spp.
- Crimean-Congo Hemorrhagic Fever (CCHF) Virus
- Cryptosporidiosis
- Cyclosporiasis
E
F
H
K
M
N
O
P
Q
S
U
V
X
No results found
Data
Nevada’s Authority for Epidemiology
Access up-to-date data on all active infectious diseases reported in Nevada.
Updates to NRS 442.010, Rapid Point-of-Care Syphilis Testing During Pregnancy
Summary Assembly Bill (AB) 360, introduced by Assemblymember Heather Goulding, was approved and signed by Governor Lombardo May 30, 2025, as part of the 83rd Nevada Legislative Session. The amendments…
Proposed Changes to Nevada Administrative Code Chapters 441A (LCB File No. R174-24)
NOTICE IS HEREBY GIVEN that the Division of Public and Behavioral Health will hold a public workshop to consider amendments to Nevada Administrative Code (NAC Chapter 441A). The workshop will…
Measles in the United States, Recommendations for Health Care Providers
Summary Measles (rubeola) activity in the United States is increasing with several outbreaks as well as several imported cases. On March 7, 2025, CDC released a Health Alert Network (HAN)…
Nevada State Public Health Laboratory Guidance for Tuberculosis and Bacillus Testing
Background The purpose of this technical bulletin is to provide guidance on two Nevada State Public Health Laboratory (NSPHL) specimen/isolate submission updates: 1) Mycobacterium tuberculosis (MTB) rapid test utilizing the…
Accelerated Testing and Surveillance for Avian Influenza A (H5N1) Human Cases
Background Avian influenza A (H5N1) has been circulating widely among birds and mammals in the United States since 2022. In spring 2024, H5N1 was detected in dairy cattle for the…
FDA Approves and Authorizes for Emergency Use Updated COVID-19 Vaccines and De-authorizes Administration of 2023-2024 COVID-19 Vaccines – Update to Recommendation
Background On August 22, 2024, the U.S. Food and Drug Administration (FDA) issued approval and granted emergency use authorization (EUA) to both Moderna and Pfizer-BioNTech for their updated mRNA COVID-19…